Native Antigen Company
Pre-clinicalWelcome to The Native Antigen Company. we are world-leading infectious disease reagents from the experts. Whether you need cutting edge reagents for your research or bulk products for manufacturing we can support all of your needs.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $40.5M
About
Welcome to The Native Antigen Company. we are world-leading infectious disease reagents from the experts. Whether you need cutting edge reagents for your research or bulk products for manufacturing we can support all of your needs.
DiagnosticsVaccinesInfectious Disease
Funding History
2Total raised:$40.5M
Series B$28MSep 15, 2023
Series A$12.5MMay 15, 2021